Eddie Joe Sullivan

Chief Executive Officer, SAB Biotherapeutics, Inc.

Companies

SAB Biotherapeutics, Inc.President Feb 23, 2024 to now¹
SAB Biotherapeutics, Inc.Board member Oct 22, 2021 to now²
SAB Biotherapeutics, Inc.Chief executive officer Oct 22, 2021 to Dec 8, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

SAB Biotherapeutics, Inc. SABS5,232,304 shares³$13.6M at $2.60Dec 7, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 7, 2023Bought 1,740 shares at $0.88 of SAB Biotherapeutics, Inc.³
Sep 7, 2022Bought 14,000 shares at $0.74 of SAB Biotherapeutics, Inc.⁴
Oct 22, 2021Granted 5,213,764 shares of SAB Biotherapeutics, Inc.⁵
Oct 7, 2021Granted 2,800 shares at $10.07 of SAB Biotherapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSAB Biotherapeutics, Inc., President
2
SEC EDGARSAB Biotherapeutics, Inc., Board member
3
SEC EDGARSAB Biotherapeutics, Inc. shares after the filing of Dec 7, 2023
4
SEC EDGARForm 4 filed Sep 8, 2022
5
SEC EDGARForm 4 filed Oct 26, 2021